c’est ce que je fais, CPUs sur Rosetta et GPU sur F@H, j’essaye de te trouver l’article;

De mémoire ils n’étudient pas tout à fait la même chose

BOINC The Berkeley Open Infrastructure for Network Computing’s (BOINC) Rosetta@homeproject

needs your help to determine the 3-dimensional shapes of proteins in

research that may ultimately lead to finding cures for some major human

diseases. By running the Rosetta program on your computer while you

don’t need it you will help us speed up and extend our research in ways

we couldn’t possibly attempt without your help. Rosetta@Home Project’s Role in Fighting Coronavirus We

are happy to report that the Rosetta molecular modeling suite was

recently used to accurately predict the atomic-scale structure of an

important coronavirus protein weeks before it could be measured in the

lab. Knowledge gained from studying this viral protein is now being used

to guide the design of novel vaccines and antiviral drugs.

Importantly,

structural biologists are quickly gaining insights into what the

proteins that make up this virus look like and how they function. One

viral protein in particular — the spike protein — allows SARS-CoV-2 to

fuse its membrane with those on human cells, leading to infection. -Institute for Protein Design Read more about the Rosetta Project and the Coronavirus here. Folding@home Similar to BOINC, Stanford University’s Folding@home

is a distributed computing project for disease research that simulates

protein folding, computational drug design, and other types of molecular

dynamics. As of today, the project is using the idle resources of

personal computers owned by volunteers from all over the world.

Thousands of people contribute to the success of this project. F@H Takes Up The Fight Against COVID-19 2019-nCoV is a close cousin to SARS coronavirus (SARS-CoV),

and acts in a similar way. For both coronaviruses, the first step of

infection occurs in the lungs, when a protein on the surface of the

virus binds to a receptor protein on a lung cell. This viral protein is

called the spike protein, depicted in red in the image below, and the receptor is known as ACE2.

A therapeutic antibody is a type of protein that can block the viral

protein from binding to its receptor, therefore preventing the virus

from infecting the lung cell. A therapeutic antibody has already been

developed for SARS-CoV, but to develop therapeutic antibodies or small

molecules for 2019-nCoV, scientists need to better understand the

structure of the viral spike protein and how it binds to the human ACE2

receptor required for viral entry into human cells.